FDA Pick Affirms Vaccine Safety but Avoids Direct Contradiction of Trump
At her confirmation hearing, FDA nominee Heidi Overton stated that all currently marketed vaccines are safe and effective, but she declined to explicitly say President Trump was wrong about the MMR vaccine. Senators, including Bill Cassidy, pressed her on whether she would resist administration efforts to alter childhood immunization schedules. Overton said she would follow statutory requirements as commissioner.
Overton's confirmation hearing unfolded against a backdrop of administration efforts to reshape vaccine policy, including a recent executive order proposing changes to childhood immunization schedules. She acknowledged that all FDA-approved vaccines, including the MMR vaccine, meet safety and efficacy standards, but she stopped short of directly challenging the president's public remarks about the vaccine's risks.
The nominee also faced questions about her previous writings on mifepristone, which she had characterized as dangerous when prescribed via mail. During the hearing, she deferred to the FDA's ongoing safety review of the drug and committed to enforcing compliance among companies that distribute it. Cassidy has not yet announced whether he will support her nomination or schedule a committee vote.
This confirmation process could shape how the FDA navigates politically charged health decisions in the coming years. If confirmed, Overton's stance on vaccines and drug approvals may influence public confidence in federal health guidance, particularly among parents weighing childhood immunization choices. Her handling of the mifepristone review could also affect reproductive health access nationwide. The outcome may signal whether the agency maintains scientific independence or becomes more aligned with administration priorities.